A team of researchers at Heriot-Watt University have said they have shown 'extremely encouraging' results in their first ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative, patient-focused treatments, today responded to recent market rumors and inquiries from ...

COCP READ THE FULL COCP RESEARCH REPORT Business Update Phase 2a Trial of CC-42344 Extended On December 31, 2024, Cocrystal ...

Elderberry juice may be a potent tool for weight management and enhancing metabolic health, according to a recent Washington ...

Tran Le was an engineering student at Stanford University when she tried to enroll in a clinical trial for her chronic ...

Topline results from a phase 2/3 clinical trial showed that an eIF2B agonist to treat ALS failed to meet its primary endpoint ...

Clinical trials are underway in Colorado for a new drug that could extend a dog’s lifespan. Loyal, a San Francisco-based ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of America addresses the company’s earnings and more.

Healthcare tech company H1 picked up Ribbon Health, a provider data management software company to broaden its reach into the health plan, provider system and digital health sectors. | Healthcare tech ...